Tag: Alzheimer’s treatment
Sanofi Acquires New Alzheimer’s Drug: Expansion of Pipeline
Sanofi Snags Vigil Neuroscience for Alzheimer's DrugSo, like, Sanofi, the French drug maker, just dropped $470 million to acquire Vigil Neuroscience, a small biotech...
Biotech Update: Roche’s TIGIT Struggles and Missed Alzheimer’s Target
Happy Tuesday! I'm Adam Feuerstein, and I'm here to bring you the latest updates in the world of biotech. It seems like all the...
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known...
BREAKING NEWS
CDC Continues Publishing Papers Despite Firing Scientists: Flagship Journal Controversy
North Carolina Kids Find Lead in Applesauce: A Closer LookIn Hickory, North Carolina, the lead-poisoning-from-applesauce case started with two little kids showing concerning blood...
